Sichuan Hebang Biotechnology Corporation Limited / Fundamentals
Income statement
- Net revenue
€905.08M - Cost of goods sold
€847.67M - Gross profit
€57.41M - SG&A expenses
-€3.23M - R&D expenses
€2.87M - EBITDA
-€19.83M - D&A
€237.16K - EBIT
-€28.09M - Interest expenses
€10.34M - EBT
-€30.46M - Tax expenses
-€4.46M - Net income
-€12.97M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€9.97M - Changes in working capital
€0.00 - Operating cash flow
€13.43M - Capex
€149.05M - Other investing cash flow
-€1.53M - Net investing cash flow
-€155.80M - Total cash dividends paid
-€32.07M - Issuance of common stock
€0.00 - Debt repayment
€678.39M - Other financing cash flow
-€101.60M - Net financing cash flow
€544.72M - Foreign exchange effects
€735.85K - Net change in cash
€474.96M - Cash at end of period
€814.64M - Free cash flow
€162.48M
Balance sheet
- Cash and cash equivalents
€816.67M - Cash and short-term investments
€816.67M - Total receivables
€212.83M - Inventory
€504.63M - Other current assets
€35.69M - Total current assets
€1.57B - Property, plant & equipment
€1.41B - Goodwill
€218.74M - Intangible assets
€122.67M - Long-term investments
€0.00 - Other non-current assets
€143.17M - Total non-current assets
€1.91B - Total assets
€3.48B - Accounts payable
€145.78M - Short-term debt
€278.54M - Other current liabilities
€75.87M - Total current liabilities
€507.67M - Long-term debt
€701.69M - Deferred tax liabilities
€22.63M - Other non-current liabilities
€0.00 - Total non-current liabilities
€739.59M - Total liabilities
€1.25B - Common stock
€1.05B - Retained earnings
€1.13B - Other equity
€0.00 - Total equity
€2.23B - Total liabilities and shareholders' equity
€3.48B
Company information
- Market capitalization
€1.75B - Employees
5.4K - Enterprise Value
€16.30B
Company ratios
- Gross margin
-
6.3% Worse than peer group: 22.4% - EBITDA margin
-
-2.2% Worse than peer group: 14.6% - EBIT margin
-
-3.1% Worse than peer group: 14.4% - EBT margin
-
-3.4% Worse than peer group: 14.5% - Net margin
-
-1.4% Worse than peer group: 10.3% - ROE
-
-0.6% Worse than peer group: 11.9% - ROA
-
-0.4% Worse than peer group: 7.0% - Asset turnover
-
26.0% Much worse than peer group: 100.4% - FCF margin
-
-15.0% Much worse than peer group: 6.6% - FCF yield
-7.8% - Efficiency ratio
102.2% - Net sales per employee
-
€168.04K - Net income per employee
-
-€2.41K